Victrelis Drug Interactions
Currently displaying 215 drugs known to have a major interaction with Victrelis (boceprevir).
- 215 major drug interactions
- 216 moderate drug interactions
- 21 minor drug interactions
Major interactions with Victrelis (boceprevir)
Note: Showing generic names only.
A
- abemaciclib
- acalabrutinib
- adagrasib
- alfentanil
- alfuzosin
- amiodarone
- apalutamide
- apixaban
- atazanavir
- atogepant
- atorvastatin
- avacopan
- avanafil
- avapritinib
- axitinib
B
- bepridil
- berotralstat
- bosutinib
- brentuximab
- brexpiprazole
- brigatinib
- brincidofovir
- bromocriptine
- budesonide
- butorphanol
C
- cabozantinib
- capivasertib
- capmatinib
- carbamazepine
- cariprazine
- ceritinib
- cerivastatin
- cilostazol
- cisapride
- cobimetinib
- colchicine
- conivaptan
- copanlisib
- crizotinib
- cyclosporine
D
- daclatasvir
- daridorexant
- darifenacin
- darunavir
- dasatinib
- deflazacort
- dihydroergotamine
- disopyramide
- docetaxel
- doxazosin
- dronedarone
- drospirenone
- duvelisib
E
- edoxaban
- elacestrant
- elagolix
- eletriptan
- eliglustat
- encorafenib
- enfortumab vedotin
- entrectinib
- enzalutamide
- eplerenone
- erdafitinib
- ergonovine
- ergotamine
- erythromycin
- eszopiclone
- ethinyl estradiol
- etonogestrel
- everolimus
F
- fedratinib
- fentanyl
- fesoterodine
- fexinidazole
- finerenone
- flibanserin
- fluticasone
- fluticasone nasal
- fosphenytoin
- fostamatinib
G
H
I
- ibrexafungerp
- ibrutinib
- iloperidone
- infigratinib
- irinotecan
- irinotecan liposomal
- isavuconazonium
- istradefylline
- ivabradine
- ivacaftor
- ivosidenib
L
- lapatinib
- larotrectinib
- lefamulin
- lemborexant
- levoketoconazole
- levomethadyl acetate
- levomilnacipran
- levonorgestrel
- lomitapide
- lonafarnib
- loperamide
- lorlatinib
- lovastatin
- lumateperone
- lurasidone
- lurbinectedin
M
- macitentan
- maraviroc
- mavacamten
- mavorixafor
- medroxyprogesterone
- methylergonovine
- methylprednisolone
- methysergide maleate
- midazolam
- midostaurin
- mifepristone
- mirvetuximab soravtansine
- mitapivat
- mitotane
- mobocertinib
N
O
P
- paclitaxel
- paclitaxel protein-bound
- pacritinib
- palbociclib
- palovarotene
- panobinostat
- pazopanib
- pemigatinib
- pexidartinib
- phenobarbital
- phenytoin
- pimavanserin
- pimozide
- pirtobrutinib
- polatuzumab vedotin
- ponatinib
- pralsetinib
- primidone
Q
R
- ranolazine
- red yeast rice
- repotrectinib
- ribociclib
- rifabutin
- rifampin
- rimegepant
- ripretinib
- rivaroxaban
- ruxolitinib
S
- salmeterol
- selpercatinib
- selumetinib
- sildenafil
- silodosin
- simeprevir
- simvastatin
- siponimod
- sirolimus
- sirolimus protein-bound
- solifenacin
- sonidegib
- sparsentan
- st. john's wort
- suvorexant
T
- tacrolimus
- tadalafil
- tamsulosin
- tazemetostat
- temsirolimus
- ticagrelor
- tisotumab vedotin
- tofacitinib
- tolvaptan
- toremifene
- trabectedin
- triamcinolone
- triazolam
U
V
- valbenazine
- vardenafil
- venetoclax
- vilazodone
- vinblastine
- vincristine
- vincristine liposome
- vinorelbine
- voclosporin
- vorapaxar
- voxelotor
Z
Victrelis alcohol/food interactions
There is 1 alcohol/food interaction with Victrelis (boceprevir).
Victrelis disease interactions
There is 1 disease interaction with Victrelis (boceprevir) which include:
More about Victrelis (boceprevir)
- Victrelis consumer information
- Check interactions
- Compare alternatives
- Reviews (3)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: protease inhibitors
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.